Cell Therapy Center EmCell offers multiple sclerosis (MS) treatment using fetal stem cells, with improvements reported in most cases. The goal of MS treatment is to terminate autoimmune aggression, that is, the internal attack against patient’s own nervous system, by disrupting the main mechanism of the disease. This, in turn, leads to the subsiding or even regression of neurological symptoms.
With MS, fetal stem cells have 2 major functions:
Within 24 years, Cell Therapy Center EmCell has treated hundreds of patients with different forms of MS and achieved improvements in 83% of cases.
After stem cell treatment, our patients report a number of improvements:
Fetal Stem Cells in Multiple Sclerosis. Poster session.
Subtypes of multiple sclerosis
Treatment of patients with remitting-relapsing multiple sclerosis
Treatment of patients with secondary progressive multiple sclerosis
Treatment of patients with primary progressive multiple sclerosis
Dynamics of neurological symptoms in 18 multiple sclerosis cases after the stem cell therapy
Patient R.W., 44. Primary progressive cerebrospinal multiple sclerosis with spastic paraparesis of the lower extremities
Patient M.C., 63. Secondary progressive multiple sclerosis with cerebrospinal involvement, spastic paraparesis of lower extremities and urine retention
Patient A.Z.D., 35. Secondary progressive multiple sclerosis with cerebrospinal involvement and spastic paraparesis of the lower extremities and urine retention
Patient B. B., 36. Secondary progressive multiple sclerosis with cerebrospinal involvement and spastic paraparesis of the lower extremities. EDSS – 5,0. Urine incontinence. Moderate type 1 diabetes mellitus
||Rezultat tretmana fetalnim matičnim ćelijama zavisi od: težine bolesti, starosne dobi pacijenta, doslednosti i privrženosti medikaciji i režimu. Rezultati tretmana, prezentovani na ovom sajtu, su individualni za svaki klinički slučaj.|